Lopez-Romero P, de la Torre I, Haladyj E, Aletaha D, et al. Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis. Ann Rheum Dis 2022 Feb 22. pii: annrheumdis-2021-221323.
PMID: 35193872